BridgeMD
New treatment option for Overactive Bladder Syndrome
Official title Oxybutynin for Post-surgical Bladder Pain and Urgency
ClinicalTrials.gov ID: NCT03952299
What this study is testing
What is Oxybutynin Transdermal Patch?
Oxybutynin Transdermal Patch is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for overactive bladder syndrome.
Also referred to as Ditropan XL.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 8
You may be able to join if
- Patients who will undergo bladder surgery that requires an indwelling bladder catheter after surgery.
- Age Range: Four to 8 years of age are eligible for the study.
You likely can't join if
- Patients who have had prior bladder surgery.
- Patients who have neurologic disease that could impair bladder sensation.
- Patients who are already taking antimuscarinic or antispasmodic medications.
- Patients with glaucoma, any neurologic disease, dementia, impaired mentation or disorder of the central nervous system.
- Patients taking any medication that affects the central nervous system such as antidepressant, anxiolytic or antipsychotic medications.
- Less than four years of age cannot have the transdermal patch due to fixed dose. Over 8 years of age: less than 5% of our patients, who undergo this...
The study team makes the final eligibility decision.
Where it's taking place
- Sacramento, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sacramento, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.